{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-422877","form_type":"8-K","ticker":"OPK","cik":"0000944809","company_name":"OPKO HEALTH, INC.","filed_at":"2026-10-15T20:07:51+00:00","discovered_at":"2026-10-15T20:09:00.272002+00:00","generated_at":"2026-10-15T20:09:07.201310+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"OPKO to sell BioReference lab testing unit to LabCorp for $722M cash plus up to $150M 4Kscore earnout","bullets":["LabCorp (Buyer) to pay OPKO/BioReference $722,000,000 in cash at closing, subject to upward or downward adjustment based on Business revenues at closing; no financing condition.","Additional earnout of up to $150,000,000 in cash over up to ten years tied to LabCorp's revenue from the 4Kscore prostate cancer test.","Assets sold include BioReference clinical/anatomic pathology testing in clinical and women's health, urology and corrections, plus the 4Kscore Test and its FDA PMA and trademark.","Closing conditioned on HSR antitrust clearance; outside date April 14, 2027, extendable by mutual agreement. Buyer owes a $28,880,000 termination fee if required government approvals fail.","OIG Determination was obtained as of the October 14, 2026 agreement date; Seller agreed to a no-shop covering alternative transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-422877","json":"https://secwatch.observer/filing/0001193125-26-422877.json","markdown":"https://secwatch.observer/filing/0001193125-26-422877.md","text":"https://secwatch.observer/filing/0001193125-26-422877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/944809/000119312526422877/0001193125-26-422877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/944809/000119312526422877/opk-20261014.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-15T20:09:07.201310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}